Description
2027 SUBCONTRACTING PLAN EFFECTIVE 7/1/2026 THOUGH 6/30/2027 FOR MELATONIN TABLETS WITH THE HARVARD DRUG GROUP, LLC DBA MAJOR PHARMACEUTICALS & THE RUGBY LABORATORIES.
Base award description: VA DOD IHS BOP FHCC OPTION 2 STATE VETERANS HOMES
Modification chain · 12 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-07-14+$0= $0
- Mod P000012022-06-27+$0= $0
- Mod P000022022-08-01+$0= $0
- Mod P000032023-06-13+$0= $0
- Mod P000042023-08-10+$0= $0
- Mod P000052024-02-14+$0= $0
- Mod P000062024-06-26+$0= $0
- Mod P000072024-07-25+$0= $0
- Mod P000082025-07-16+$0= $0
- Mod P000092025-07-21+$0= $0
- Mod P000102026-05-04+$0= $0
- Mod P000112026-08-10+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-07-14 | +$0 | $0 | VA DOD IHS BOP FHCC OPTION 2 STATE VETERANS HOMES |
| Mod P00001· ADD SUBCONTRACTING PLAN | 2022-06-27 | +$0 | $0 | 2022 SUBCONTRACTING PLAN FOR MELATONIN TABLETS WITH THE HARVARD DRUG GROUP, LLC DBA MAJOR PHARMACEUTICALS & TH… |
| Mod P00002· EXERCISE AN OPTION | 2022-08-01 | +$0 | $0 | EXERCISE OPTION YEAR 1 EFFECTIVE 9/15/2022 THROUGH 9/14/2023 FOR MELATONIN TABLETS WITH THE HARVARD DRUG GROUP… |
| Mod P00003· ADD SUBCONTRACTING PLAN | 2023-06-13 | +$0 | $0 | INCORPORATE 2023 SUBCONTRACTING PLAN EFFECTIVE 7/1/2023 THROUGH 6/30/2024 FOR MELATONIN TABLETS WITH THE HARVA… |
| Mod P00004· EXERCISE AN OPTION | 2023-08-10 | +$0 | $0 | EXERCISE OPTION YEAR 2 EFFECTIVE 9/15/2023 THROUGH 9/14/2024 FOR MELATONIN TABLETS WITH THE HARVARD DRUG GROUP… |
| Mod P00005· OTHER ADMINISTRATIVE ACTION | 2024-02-14 | +$0 | $0 | CRF AND SUBMISSION OF QUARTERLY SALES REPORTS EFFECTIVE 2/14/2024 FOR MELATONIN TABLETS WITH THE HARVARD DRUG… |
| Mod P00006· ADD SUBCONTRACTING PLAN | 2024-06-26 | +$0 | $0 | 2024 SUBCONTRACTING PLAN EFFECTIVE 7/1/2024 THOUGH 6/30/2025 FOR MELATONIN TABLETS WITH THE HARVARD DRUG GROUP… |
| Mod P00007· EXERCISE AN OPTION | 2024-07-25 | +$0 | $0 | EXERCISE OPTION YEAR 3 EFFECTIVE 9/15/2024 THOUGH 9/14/2025 FOR MELATONIN TABLETS WITH THE HARVARD DRUG GROUP,… |
| Mod P00008· ADD SUBCONTRACTING PLAN | 2025-07-16 | +$0 | $0 | 2026 SUBCONTRACTING PLAN EFFECTIVE 7/1/2025 THOUGH 6/30/2026 FOR MELATONIN TABLETS WITH THE HARVARD DRUG GROUP… |
| Mod P00009· EXERCISE AN OPTION | 2025-07-21 | +$0 | $0 | EXERCISE OPTION YEAR 4 EFFECTIVE 9/15/2025 THOUGH 9/14/2026 FOR MELATONIN TABLETS WITH THE HARVARD DRUG GROUP,… |
| Mod P00010· ENTITY ADDRESS CHANGE | 2026-05-04 | +$0 | $0 | UPDATE THE CORPORATE ADDRESS OF THE VENDOR. |
| Mod P00011· ADD SUBCONTRACTING PLAN | 2026-08-10 | +$0 | $0 | 2027 SUBCONTRACTING PLAN EFFECTIVE 7/1/2026 THOUGH 6/30/2027 FOR MELATONIN TABLETS WITH THE HARVARD DRUG GROUP… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CBGGKKVNJBK9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36F79725D0121 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36E79725D0010 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36E79725D0001 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36E79722D0017 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2022 |
| 36E79721D0038 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2021 |
| 36F79719D0033 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2019 |
Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36E79726A0025 | CHIESI USA INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0024 | NEUROTECH PHARMACEUTICALS, INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0023 | TAKEDA PHARMACEUTICALS AMERICA, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0041 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0022 | AURINIA PHARMA US INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79721D0048_3600 · retrieved 2026-09-26.